CHC Healthcare Group

TWSE:4164 Voorraadrapport

Marktkapitalisatie: NT$7.3b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

CHC Healthcare Group Beheer

Beheer criteriumcontroles 2/4

De CEO CHC Healthcare Group's is Ming-Lun Lee, benoemd in Jul2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.006% van de aandelen van het bedrijf, ter waarde NT$ 425.31K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.6 jaar en 10.3 jaar.

Belangrijke informatie

Ming-Lun Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEO0.006%
Management gemiddelde ambtstermijn3.6yrs
Gemiddelde ambtstermijn bestuur10.3yrs

Recente managementupdates

Recent updates

CHC Healthcare Group (TWSE:4164) Will Pay A Larger Dividend Than Last Year At NT$2

Jun 29
CHC Healthcare Group (TWSE:4164) Will Pay A Larger Dividend Than Last Year At NT$2

CHC Healthcare Group's (TWSE:4164) Dividend Will Be Increased To NT$2.01

Jun 15
CHC Healthcare Group's (TWSE:4164) Dividend Will Be Increased To NT$2.01

If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%

Mar 08
If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%

CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 07
CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?

Jan 21
Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?

Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?

Jan 06
Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?

Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?

Dec 22
Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?

CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years

Dec 07
CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years

Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Nov 22
Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?

CEO

Ming-Lun Lee

less than a year

Tenure

Mr. Ming-Lun Lee serves as President at CHC Healthcare Group since July 2024. He served as Chief Operating Officer at CHC Healthcare Group since March 19, 2021 until December 18, 2023 and served as its Vic...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Pei-Lin Lee
Chairman & Human Resources Officer14.9yrsNT$11.06m6.37%
NT$ 464.0m
Tien-Ying Lee
Vice Chairman & Chief Information Officer14.9yrsNT$9.10m5.66%
NT$ 411.9m
Ming-Lun Lee
Presidentless than a yeargeen gegevens0.0058%
NT$ 425.3k
Yi-Chun Chen
CFO, Corporate Governance Officer & Company Secretary5.6yrsgeen gegevens0.030%
NT$ 2.2m
Yee-Min Jen
Chief Executive Officer of Oncology Business Group10.4yrsgeen gegevens0.036%
NT$ 2.6m

3.6yrs

Gemiddelde duur

Ervaren management: Het managementteam van 4164 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Pei-Lin Lee
Chairman & Human Resources Officer14.9yrsNT$11.06m6.37%
NT$ 464.0m
Tien-Ying Lee
Vice Chairman & Chief Information Officer14.9yrsNT$9.10m5.66%
NT$ 411.9m
Yung-Shun Chuang
Director10.3yrsNT$848.00kgeen gegevens
Geng-Wang Laiw
Independent Director10.3yrsNT$956.00kgeen gegevens
Chun-Shung Huang
Director12.8yrsNT$848.00kgeen gegevens
Chih Chi
Independent Director1.3yrsgeen gegevensgeen gegevens
Ming-Liang Kao
Independent Director1.3yrsgeen gegevensgeen gegevens

10.3yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 4164 zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.3 jaar).